Detection of invasive infection caused by Fusarium solani and non-Fusarium solani species using a duplex quantitative PCR-based assay in a murine model of fusariosis

Medical Mycology

Volumn 50, Issue 3, 2012, Pages 270-275

  Bernal Martnez, Leticia ^a   Buitrago, Maria J ^a   Castelli, Maria V ^a   Rodrguez Tudela, Juan L ^a   Cuenca Estrella, Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

DNA detection; Early diagnosis; Emerging pathogens

Indexed keywords

RIBOSOME DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DISEASE MODEL; DNA DETERMINATION; FUNGAL DETECTION; FUNGAL GENE; FUNGAL STRAIN; FUSARIOSIS; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; GENE TARGETING; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; LUNG PARENCHYMA; MALE; MOLECULAR BEACON; MOUSE; NONHUMAN; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SERUM; SYSTEMIC MYCOSIS; VALIDATION STUDY;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, FUNGAL; FUSARIOSIS; FUSARIUM; MALE; MICE; MICE, INBRED ICR; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOLOGY; OLIGONUCLEOTIDE PROBES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERUM;

ANIMALIA; FUSARIUM; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; MURINAE;

EID: 84858405633     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.604047     Document Type: Review

References (32)

1. Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35: 909-920. (Pubitemid 35178307)
2. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20: 695-704. (Pubitemid 47623773)
3. Lionakis MS, Kontoyiannis DP. Fusarium infections in critically ill patients. Semin Respir Crit Care Med 2004; 25: 159-169. (Pubitemid 38544248)
4. Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7: 479-504. (Pubitemid 24317876)
5. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004; 10 (Suppl. 1): 67-75. (Pubitemid 38379952)
6. Guarro J, Gene J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995; 14: 741-754.
7. Raad I, Tarrand J, Hanna H, et al. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol 2002; 23: 532-537. (Pubitemid 35033865)
8. Torres HA, Raad II, Kontoyiannis DP. Infections caused by Fusarium species. J Chemother 2003; 15 (Suppl. 2): 28-35. (Pubitemid 38021613)
9. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzon A, Mellado E, Rodriguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008; 61: 805-809. (Pubitemid 351426063)
10. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, et al. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and flamentous fungi. Antimicrob Agents Chemother 2006; 50: 917-921. (Pubitemid 43327795)
11. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, et al. Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrob Agents Chemother 2009; 53: 2192-2195.
12. Guarro J, Pujol I, Mayayo E. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani. Antimicrob Agents Chemother 1999; 43: 1256-1257. (Pubitemid 29214756)
13. Cornely OA. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection 2008; 36: 296-313.
14. Mayayo E, Pujol I, Guarro J. Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol 1999; 48: 363-366. (Pubitemid 29478863)
15. Azor M, Gene J, Cano J, Guarro J. Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother 2007; 51: 1500-1503. (Pubitemid 46586837)
16. Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1->3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009; 49: 1650-1659.
17. Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections-a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46: 1864-1870.
18. Buitrago MJ, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Detection of Aspergillus spp. real time in a mouse model of lung infection. Enferm Infecc Microbiol Clin 2005; 23: 464-468. (Pubitemid 41542666)
19. Tang CM, Cohen J, Holden DW. An Aspergillus fumigatus alkaline protease mutant constructed by gene disruption is deficient in extracellular elastase activity. Mol Microbiol 1992; 6: 1663-1671.
20. Sambrook JE, Fritsch F, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. NY: Cold Spring Harbor Laboratory Press; 1989.
21. Castelli MV, Buitrago MJ, Bernal-Martinez L, et al. Development and validation of a quantitative PCR assay for diagnosis of scedo-sporiosis. J Clin Microbiol 2008; 46: 3412-3416.
22. Smith JM, Tang CM, Van Noorden S, Holden DW. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun 1994; 62: 5247-5254. (Pubitemid 24364960)
23. O'Donnell K, Sutton DA, Rinaldi MG, et al. Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin. J Clin Microbiol 2004; 42: 5109-5120. (Pubitemid 39506218)
24. O'Donnell K, Sutton DA, Rinaldi MG, et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 2010; 48: 3708-3718.
25. Skovgaard K, Rosendahl S, O'Donnell K, Nirenberg HI. Fusarium commune is a new species identified by morphological and molecular phylogenetic data. Mycologia 2003; 95: 630-636. (Pubitemid 37231933)
26. Balajee SA, Borman AM, Brandt ME, et al. Sequence-based identification of Aspergillus, Fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol 2009; 47: 877-884.
27. Hue FX, Huerre M, Rouffault MA, de Bievre C. Specific detection of Fusarium species in blood and tissues by a PCR technique. J Clin Microbiol 1999; 37: 2434-2438. (Pubitemid 29337257)
28. Ahmad S, Khan ZU, Theyyathel AM. Development of a nested PCR assay for the detection of Fusarium solani DNA and its evaluation in the diagnosis of invasive fusariosis using an experimental mouse model. Mycoses 2010; 53: 40-47.
29. Lau A, Sorrell TC, Chen S, et al. Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol 2008; 46: 3021-3027.
30. Spiess B, Seifarth W, Hummel M, et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol 2007; 45: 3743-3753. (Pubitemid 350156875)
31. Campa D, Tavanti A, Gemignani F, et al. DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses. J Clin Microbiol 2008; 46: 909-915. (Pubitemid 351379978)
32. Jaeger EE, Carroll NM, Choudhury S, et al. Rapid detection and iden-tification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR. J Clin Microbiol 2000; 38: 2902-2908. (Pubitemid 30640571)